Skip to main content
Presentation
Intravenous Granisetron versus Ondansetron in the Prevention of Cyclophosphamide-Doxorubicin Induced Emesis in Breast Cancer Patients: A Double-blind Crossover Study
American Society of Clinical Oncology Annual Meeting (1996)
  • Paul R Kaywin
Publication Date
1996
Location
Philadelphia, PA
Comments
Additional authors: Perez, E.A., Lembersky, B., Kalman, L., Friedman, L
Citation Information
Paul R Kaywin. "Intravenous Granisetron versus Ondansetron in the Prevention of Cyclophosphamide-Doxorubicin Induced Emesis in Breast Cancer Patients: A Double-blind Crossover Study" American Society of Clinical Oncology Annual Meeting (1996)
Available at: http://works.bepress.com/paul-kaywin/8/